Internal Medicine · Common solid tumors · David Aldana

Internal Medicine · Clinical Specialties

How it begins

Compendio exhaustivo de los principios oncológicos generales y de los tumores sólidos de mayor prevalencia en la práctica clínica internista: epidemiología, biología molecular, presentación, diagnóstico, estadificación, terapéutica contemporánea y correlaciones clínicas.

What it covers

1. Chapter 1 Carcinogenesis and hallmarks of cancer
2. · § 1.1 Clonal nature of cancer
3. · § 1.2 The hallmarks of cancer
4. · § 1.3 Oncogenes and suppressor genes
5. · § 1.4 The tumor microenvironment
6. · § 1.5 Carcinogens
7. Chapter 2 Staging, markers and patient evaluation
8. · § 2.1 The TNM system
9. · § 2.2 ECOG and Karnofsky
10. · § 2.3 Serum tumor markers
11. · § 2.4 Molecular pathology and precision oncology
12. · § 2.5 Imaging in oncology
13. Chapter 3 Paraneoplastic syndromes
14. · § 3.1 Definition and mechanisms
15. · § 3.2 Endocrine syndromes
16. · § 3.3 Paraneoplastic neurological syndromes
17. · § 3.4 Hematological syndromes
18. · § 3.5 Mucocutaneous and rheumatological syndromes
19. · § 3.6 Oncological cachexia
20. Chapter 4 Oncological emergencies
21. · § 4.1 Superior vena cava syndrome (SVCS)
22. · § 4.2 Metastatic spinal cord compression
23. · § 4.3 Tumor lysis syndrome (TLS)
24. · § 4.4 Febrile neutropenia
25. · § 4.5 Malignant hypercalcemia
26. · § 4.6 Other emergencies
27. Chapter 5 Oncological screening programs
28. Chapter 6 Lung cancer
29. · § 6.1 Epidemiology and risk factors
30. · § 6.2 Histological classification
31. · § 6.3 NSCLC Molecular Biology
32. · § 6.4 Clinical manifestations
33. · § 6.5 Diagnosis
34. · § 6.6 Staging and treatment
35. Chapter 7 Esophageal cancer
36. · § 7.1 Epidemiology and risk factors
37. · § 7.2 Clinic
38. · § 7.3 Diagnosis and staging
39. · § 7.4 Treatment
40. Chapter 8 Gastric cancer
41. · § 8.1 Risk factors
42. · § 8.2 Lauren's classification
43. · § 8.3 Clinic
44. · § 8.4 Diagnosis and treatment
45. Chapter 9 Colorectal cancer
46. · § 9.1 Risk factors
47. · § 9.2 Colonic carcinogenesis
48. · § 9.3 Clinic
49. · § 9.4 Diagnosis, staging and molecular
50. · § 9.5 Treatment
51. Chapter 10 Hepatocellular carcinoma
52. · § 10.1 Risk factors
53. · § 10.2 Screening
54. · § 10.3 Clinic
55. · § 10.4 Diagnosis
56. · § 10.5 BCLC staging and treatment
57. Chapter 11 Pancreatic cancer
58. · § 11.1 Risk factors
59. · § 11.2 Clinic
60. · § 11.3 Diagnosis
61. · § 11.4 Treatment
62. Chapter 12 Prostate cancer
63. · § 12.1 Epidemiology and risk factors
64. · § 12.2 Screening and diagnosis
65. · § 12.3 Classification: Gleason and ISUP groups
66. · § 12.4 Staging
67. · § 12.5 Treatment
68. Chapter 13 Renal cell carcinoma
69. · § 13.1 Risk factors
70. · § 13.2 Histological classification
71. · § 13.3 Clinic
72. · § 13.4 Diagnosis and treatment
73. Chapter 14 Bladder cancer
74. · § 14.1 Risk factors
75. · § 14.2 Clinic
76. · § 14.3 Diagnosis and treatment
77. Chapter 15 Breast cancer
78. · § 15.1 Risk factors
79. · § 15.2 Molecular classification
80. · § 15.3 Clinic
81. · § 15.4 Diagnosis
82. · § 15.5 Treatment
83. Chapter 16 Cervical cancer
84. · § 16.1 HPV and carcinogenesis
85. · § 16.2 Screening and prevention
86. · § 16.3 Clinic and diagnosis
87. · § 16.4 Treatment
88. Chapter 17 Endometrial cancer
89. · § 17.1 Risk factors and classification
90. · § 17.2 Clinic, diagnosis and treatment
91. Chapter 18 Ovarian cancer
92. · § 18.1 Risk factors
93. · § 18.2 Histology
94. · § 18.3 Clinic and diagnosis
95. · § 18.4 Treatment
96. Chapter 19 Thyroid cancer
97. · § 19.1 Histological classification
98. · § 19.2 Study of the thyroid nodule
99. · § 19.3 Treatment
100. Chapter 20 Cutaneous melanoma
101. · § 20.1 Risk factors
102. · § 20.2 ABCDE and clinical subtypes
103. · § 20.3 Diagnosis, staging and biology
104. · § 20.4 Treatment
105. Selected bibliography